We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
1
1 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Not yet recruiting
100.0%
No approval data available
- NEOM has signed a strategic memorandum of understanding with WuXi AppTec to explore localization of pharmaceutical research, development and manufacturing capabilities in Saudi Arabia. - The partnership aims to create world-class CRDMO facilities at Oxagon, NEOM's advanced manufacturing city, supporting Saudi Arabia's economic diversification and biotechnology ambitions. - This collaboration represents a significant step forward in advancing the Kingdom's National Biotech Strategy as part of Saudi Vision 2030. - The agreement leverages WuXi AppTec's decades of biopharmaceutical innovation experience with NEOM's state-of-the-art clean manufacturing infrastructure to serve regional and global markets.
